Suono Bio Inc.

Cambridge, MA · Founded 2016 · Biotech · Private

Ultrasound-based platform for local delivery of nucleic acid therapeutics to tissue

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · suonobio.com

Sector: Biotech
Headquarters: Cambridge, MA
Founded: 2016
Latest Form D: $500K, Aug 2023
Total capital: $9M

Federal grants: $527K; 2 awards · 2019; Rank in peer group#6 of 22
Private capital raised: $8.5M; 3 Form D · last Aug 2023; 38 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 24 pending

Capital timeline

Latest events

Aug 2023Private capital raisedForm D · SEC · 3rd filing$500K
Mar 2021Private capital raisedForm D · SEC · 2nd filing$6.7M
May 2019Federal grantHealth and Human S · Phase I · Ultrasound as a platform for formulation and sequence-independent delivery of nucleic acids$263K
Apr 2019Federal grantHealth and Human S · Phase I · Ultrasound as a platform for formulation and sequence-independent delivery of nucleic acids$263K
Jun 2017Private capital raisedForm D · SEC · 1st filing$1.3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 22 peers

Line = median

Biotech · Device

Federal grants#6 · top 27%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Carl SchoellhammerResearcherExecutive Officer, DirectorLinked by $263K in grants as PI
Amy SchulmanDirectorNamed in SEC Form D filings
FREDERICK SHANEDirectorNamed in SEC Form D filings
Giovanni TraversoDirectorNamed in SEC Form D filings
Robert LangerDirectorNamed in SEC Form D filings
SCOTT KELLOGGExecutive Officer, DirectorNamed in SEC Form D filings

Show all 7 people

VICTORIA WANGDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 24

Jun 20, 2024PendingSystem Containing Ingestible Ultrasound Device For Delivery Of Therapeutic AgentsUSPTOApplication 18287086
Nov 16, 2023PendingUltrasound Flexural WaveguideUSPTOApplication 18026027
Oct 14, 2021PendingTethered Ultrasound Devices And Uses ThereofUSPTOApplication 17282066

Show all 24 patent records

System Containing Ingestible Ultrasound Device For Delivery Of Therapeutic AgentsJun 20, 2024 · Application 18287086Pending
Ultrasound Flexural WaveguideNov 16, 2023 · Application 18026027Pending
Tethered Ultrasound Devices And Uses ThereofOct 14, 2021 · Application 17282066Pending
Devices And Methods For Ultrasonic Delivery Of An Agent Within An Oral CavityAug 19, 2021 · Application 17259223Pending
Integrated Ingestible Ultrasound Device For Delivery Of Therapeutic AgentsApplication 63409880Pending
Low Power High-volume Efficiency Ingestible Ultrasound Device For Delivery Of Therapeutic AgentsApplication 63402579Pending
Ultrasound Mediated Drug Delivery Using Strap WaveguidesApplication 63350225Pending
System Containing Ingestible Ultrasound Device For Delivery Of Therapeutic AgentsApplication PCTUS2022024987Pending
Ultrasouind-mediated Drug Delivery Via Radial EmissionApplication 63272393Pending
Ultrasound Flexural WaveguideApplication PCTUS2021050063Pending
Ultrasound Flexural WaveguideApplication 63222114Pending
System Containing Ingestible Ultrasound Device For Delivery Of Therapeutic AgentsApplication 63176643Pending
Ultrasound Flexural WaveguideApplication 63077903Pending
Tethered Ultrasound Devices And Uses ThereofApplication PCTUS2019055834Pending
Devices And Methods For Ultrasonic Delivery Of An Agent Within An Oral CavityApplication PCTUS2019042519Pending
Devices And Methods For Ultrasonic Delivery Of An Agent Within An Oral CavityApplication 62791277Pending
Ultrasound Methods For Delivery Of Drugs To WoundsApplication 62757842Pending
Tethered Ultrasound Devices And Uses ThereofApplication 62755065Pending
Ultrasound-based Immunization And ImmunotherapyApplication 62744224Pending
Ultrasound Methods For Delivery Of Drugs To WoundsApplication 62744232Pending
Ultrasound For Delivery Of An Agent Within An Oral CavityApplication 62701408Pending
Integrated Ingestible Ultrasound Device For Delivery Of Therapeutic AgentsApplication PCTUS2023033214Pending
Low Power High-volume Efficiency Ingestible Ultrasound Device For Delivery Of Therapeutic AgentsApplication PCTUS2023030685Pending
Ultrasound-mediated Drug DeliveryApplication PCTUS2022048029Pending

AXONIS THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
KIYATEC, LLCSimilar federal contract value in Biotech · null in contracts
Mitokinin, Inc.Similar federal contract value in Biotech · null in contracts
EnBiotix, Inc.Similar federal contract value in Biotech · null in contracts
MIMIVAX, LLCSimilar federal contract value in Biotech · null in contracts
T3D Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.